Facioscapulohumeral muscular dystrophy's game of homeodomains: therapy wants a biomarker as a sword wants a whetstone.

Published in: Brain communications (2023)

This scientific commentary refers to 'The FSHD muscle-blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy', by Banerji et al . (https://doi.org/10.1093/braincomms/fcad221).

Keyphrases

muscular dystrophy
duchenne muscular dystrophy
skeletal muscle
single cell
bone marrow
cell therapy
virtual reality